Amendment· HAMDTHAMDT 58 (119th)passed
United States · United States Congress
Bill· HRH.R. 10645 (119th)referred
United States · United States Congress · 1 October 2026
Bill· HRH.R. 10628 (119th)referred
United States · United States Congress · 28 September 2026
Bill· HRH.R. 10615 (119th)referred
United States · United States Congress · 28 September 2026
Bill· HRH.R. 10633 (119th)referred
United States · United States Congress · 28 September 2026
Bill· HRH.R. 10625 (119th)referred
United States · United States Congress · 28 September 2026
Bill· HRH.R. 10224 (119th)referred
United States · United States Congress · 2 September 2026
This bill designates the facility of the United States Postal Service located at 6 Pennsylvania Avenue in Matamoras, Pennsylvania, as the "PFC Edward Kuhn Memorial Post Office".
Bill· HRH.R. 10166 (119th)referred
United States · United States Congress · 27 August 2026
Bill· HRH.R. 9984 (119th)referred
United States · United States Congress · 30 July 2026
Bill· HRH.R. 9970 (119th)referred
United States · United States Congress · 27 July 2026
Bill· HJRESH.J.Res. 205 (119th)referred
United States · United States Congress · 23 July 2026
Bill· HRH.R. 9829 (119th)referred
United States · United States Congress · 22 July 2026
Bill· HRH.R. 9693 (119th)referred
United States · United States Congress · 15 July 2026
Bill· HRH.R. 9599 (119th)referred
United States · United States Congress · 6 July 2026
Bill· HRH.R. 9509 (119th)referred
United States · United States Congress · 29 June 2026
Bill· HRH.R. 9418 (119th)referred
United States · United States Congress · 24 June 2026
Access to Innovative Treatments Act of 2026 This bill requires the Centers for Medicare & Medicaid Services (CMS) to review adverse national coverage determinations of drugs under Medicare within 30 days of receiving a request to do so. Specifically, the CMS must review within 30 days any denials or limitations of coverage that are inconsistent with the drug's approval by the Food and Drug Administration (FDA). The bill's requirements do not apply if the CMS already conducted such a review within a two-year period. The bill also prohibits the CMS from applying prior coverage determinations that were made for drugs before they were approved by the FDA if such determinations are inconsistent with the drug's approval.
Bill· HRH.R. 9392 (119th)open
United States · United States Congress · 23 June 2026
Bill· HRH.R. 9332 (119th)reported
United States · United States Congress · 18 June 2026
Bill· HRH.R. 9340 (119th)reported
United States · United States Congress · 18 June 2026
Resolution· HRESH.Res. 1331 (119th)referred
United States · United States Congress · 2 June 2026
Bill· HRH.R. 9000 (119th)referred
United States · United States Congress · 21 May 2026
Bill· HRH.R. 9002 (119th)referred
United States · United States Congress · 21 May 2026
Small Practice, Underserved, and Rural Support Program Extension Act of 2023 or the SURS Extension Act This bill reauthorizes funds through FY2031 for the Centers for Medicare & Medicaid Services to contract with specified entities (e.g., quality improvement organizations) to provide technical assistance regarding the Merit-based Incentive Payment System (MIPS) and alternative payment models under Medicare, specifically for health professionals in practices with 15 or fewer professionals. (MIPS is an incentive program under Medicare that allows health professionals to receive payment adjustments based on certain performance measures.)
Bill· HRH.R. 8413 (119th)referred
United States · United States Congress · 21 April 2026
Bill· HRH.R. 8414 (119th)referred
United States · United States Congress · 21 April 2026
Showing the 24 most recent records of 891. Browse the full list